Informa plc (LON:INF) Receives GBX 1,076.43 Average Price Target from Brokerages

Informa plc (LON:INF) has been assigned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is GBX 1,076.43.

Several research analysts recently issued reports on INF shares. JPMorgan Chase & Co. cut their target price on shares of Informa from GBX 1,345 to GBX 1,330 and set an “overweight” rating for the company in a research report on Monday, January 12th. Citigroup cut their target price on shares of Informa from GBX 1,000 to GBX 850 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Finally, Berenberg Bank reiterated a “buy” rating and issued a GBX 1,030 target price on shares of Informa in a research report on Wednesday, January 21st.

Informa Trading Up 0.1%

Informa stock opened at GBX 797.13 on Wednesday. Informa has a fifty-two week low of GBX 711.20 and a fifty-two week high of GBX 1,000. The firm’s fifty day moving average price is GBX 790.60 and its 200-day moving average price is GBX 869.74. The stock has a market cap of £10.09 billion, a P/E ratio of 996.41, a PEG ratio of 0.75 and a beta of 0.69. The company has a debt-to-equity ratio of 61.56, a quick ratio of 1.70 and a current ratio of 0.44.

Informa (LON:INF) last announced its earnings results on Thursday, March 12th. The company reported GBX 56 earnings per share (EPS) for the quarter. Informa had a net margin of 1.64% and a return on equity of 0.87%. Equities research analysts forecast that Informa will post 59.3240265 earnings per share for the current fiscal year.

About Informa

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.